SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-045990
Filing Date
2017-07-21
Accepted
2017-07-21 17:07:32
Documents
2
Period of Report
2017-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1637
2 EX-24 DOCUMENT attachment1.htm EX-24 3530
  Complete submission text file 0001209191-17-045990.txt   6791
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DARE BIOSCIENCE, INC. 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Walters-Hoffert Lisa (Reporting) CIK: 0001711576 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 17977139